Evidence-based pharmacogenetic guidelines in the netherlands

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: CHEUNG, Ka-Chun (Royal Dutch Pharmacists Association, Medicine Information Centre, DEN HAAG, Netherlands)
  • Co-author(s): Ka-Chun Cheung:
    Marga Nijenhuis: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
    Mandy Crommentuijn – van Rhenen: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
    Inge Holsappel: Medicine Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
  • Abstract:

    Methods


    For each gene-drug interaction a systematic literature search in Pubmed, SmPC and the European Public Assessment Report will be performed. During the data assessment two parameters are defined: level of evidence and clinical relevance of the gene-drug interaction. The DPWG discusses and endorses the proposed dosing recommendations and risk


    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login